Pall (BUE:PLL) Change In Payables And Accrued Expense : ARS0.00 Mil (TTM As of Apr. 2015)

View and export this data going back to . Start your Free Trial

What is Pall Change In Payables And Accrued Expense?

Pall's Change In Payables And Accrued Expense for the quarter that ended in Apr. 2015 was ARS0.00 Mil. It means Pall's Accounts Payable & Accrued Expense stayed the same from Jan. 2015 to Apr. 2015 .

Pall's Change In Payables And Accrued Expense for the fiscal year that ended in Jul. 2014 was ARS0.44 Mil. It means Pall's Accounts Payable & Accrued Expense increased by ARS0.44 Mil from Jul. 2013 to Jul. 2014 .

Pall Change In Payables And Accrued Expense Historical Data

The historical data trend for Pall's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pall Change In Payables And Accrued Expense Chart

Pall Annual Data

Trend

Jul05

Jul06

Jul07

Jul08

Jul09

Jul10

Jul11

Jul12

Jul13

Jul14

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

235.34

163.00

383.96

-673.48

0.44

Pall Quarterly Data
	Jul10	Oct10	Jan11	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Pall Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Apr. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS0.00 Mil.

Pall Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Pall's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Pall (BUE:PLL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Pall Corporation (BUE:PLL) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.pall.com

Pall Corporation is a New York corporation incorporated on July 31, 1946. The Company supplies filtration, separation and purification technologies. Its products are used to remove solid, liquid and gaseous contaminants from a variety of liquids and gases. Its serves its customers through two businesses: Life Sciences and Industrial. The Life Sciences business group is engaged in developing, manufacturing and selling products to customers in the BioPharmaceutical, Food & Beverage and Medical markets. The Industrial business group is engaged in developing, manufacturing and selling products to customers in the Process Technologies, Aerospace and Microelectronics markets. The Life Sciences technologies facilitate the process of drug discovery, development, regulatory validation and production, and are used in research laboratories, and the pharmaceutical and biotechnology industries. It also supplies products and technologies for food and beverage industries and in hospitals at the point of patient care. The Industrial segment provides enabling and process-enhancing technologies throughout the industrial marketplace. These include the Process Technologies, Aerospace and Microelectronics markets. It has the capability to provide customers with integrated solutions using its proprietary consumable filtration products for their process fluids. The Company's competition varies by product and application. Its competitors in the BioPharmaceuticals market include Merck Millipore (a division of Merck KGaA), The Sartorius Group and GE Healthcare (a unit of General Electric Company ("GE")). Its competitors in the Food & Beverage market include 3M Purification, Pentair, Inc., Filtrox Group, The Sartorius Group, Eaton Corporation and Parker Domnick Hunter (a division of Parker Hannifin). Its competitors in the Medical market include Merck Millipore, GE Healthcare, Teleflex Incorporated, Covidien plc and Intersurgical, Ltd. Its competitors in the Process Technologies market include CLARCOR Inc., Donaldson Company, Inc., Parker Hannifin Corporation, HYDAC International GmbH, GE Infrastructure (a unit of GE), Pentair, Inc., 3M Purification, U.S. Filter (a unit of Siemens AG) and ESCO Technologies Inc. Its competitors in the Aerospace market include Donaldson Company, Inc. and ESCO Technologies Inc. Its competitors in the Microelectronics market include Entegris, Inc., Parker Hannifin Corporation and Mott Corporation. The Company is subject to competition in all of the global markets in which it operates.